RESCUE and REVERSE Long-term Follow-up
Condition(s):Leber Hereditary Optic NeuropathyLast Updated:January 25, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Leber Hereditary Optic NeuropathyLast Updated:January 25, 2024Completed
Condition(s):Dry Age-related Macular DegenerationLast Updated:April 2, 2021Completed
Condition(s):Retinoschisis; X-LinkedLast Updated:November 18, 2023Active, not recruiting
Condition(s):Leber’s Hereditary Optic NeuropathyLast Updated:December 8, 2023Active, not recruiting
Condition(s):Leber Hereditary Optic Neuropathy (LHON)Last Updated:January 18, 2024Recruiting
Condition(s):Leber Hereditary Optic Neuropathy (LHON)Last Updated:December 12, 2023Recruiting
Condition(s):Neovascular Age-related Macular Degeneration; Wet Age-related Macular DegenerationLast Updated:May 16, 2023Completed
Condition(s):Wet Age-related Macular Degeneration; Neovascular Age-related Macular DegenerationLast Updated:August 8, 2023Completed
Condition(s):Leber’s Hereditary Optic Neuropathy (LHON)Last Updated:November 14, 2022Recruiting
Condition(s):Neuronal Ceroid Lipofuscinosis Type 2Last Updated:November 30, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.